By Editor • September 1, 2026 • 1 min read
On Monday, the Trump administration revealed that another group of pharmaceutical companies has committed to reducing drug prices to align with international rates.
However, specifics of these agreements remain undisclosed, raising concerns about potential tariff exemptions or Medicare pricing programs.
Source: www.statnews.com
#drug pricing #health care #Medicare #pharmaceuticals #Trump
By Editor • September 1, 2026 • 2 min read
The 'knees over toes' exercise trend challenges traditional fitness advice, promoting knee strength through controlled movement.
Read moreBy Editor • September 1, 2026 • 1 min read
Superpower offers a cutting-edge approach to health monitoring, enabling individuals to take charge of their wellness through comprehensive testing and personalized insights.
Read moreBy Editor • September 1, 2026 • 1 min read
Novartis makes strides in multiple sclerosis treatment with a new BTK inhibitor, while Alumis faces setbacks in lupus trials.
Read more
